Download 
|
< Back |
| 01:38 PM | |
| Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Tuesday, May 20, 2025 at 05:00 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2025. | |
| View all announcements for Marksans Pharma Ltd | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback